Kamui Pharma

Developer of probiotic medicines for gastrointestinal diseases

placeAsahikawa, Hokkaido, Japan calendar_todayFounded 2018 language kamuipharma.co.jp

Innovation

5 patent families — focus: Human necessities; filing pace accelerating. Cited 54 times.

YearFilings
20211
20221
20243
20252
20262

Investor mix

5 investors on record; lead investors include Mitsubishi UFJ Capital, Cyberdyne, DG Ventures, Hokkaido Venture Capital.

Investor typeCountShare
Venture capital360%
Other / undisclosed240%
Coming soon